List of Jazz Pharmaceuticals patents

Patents where

Current Assignee

Name

Jazz Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11400052 Alcohol-resistant drug formulations	Patent 11400052 was granted and assigned to Jazz Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	11400052	August 2, 2022
‌ US Patent 10912754 Methods and compositions for treating excessive sleepiness	Patent 10912754 was granted and assigned to Jazz Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	10912754	February 9, 2021
‌ US Patent 10940133 Methods of providing solriamfetol therapy to subjects with impaired renal function	Patent 10940133 was granted and assigned to Jazz Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	10940133	March 9, 2021
‌ US Patent 9050302 Method of administration of gamma hydroxybutyrate with monocarboxylate transporters	Patent 9050302 was granted and assigned to Jazz Pharmaceuticals on June, 2015 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	9050302	June 9, 2015
‌ US Patent 10213400 Method of administration of gamma hydroxybutyrate with monocarboxylate transporters	Patent 10213400 was granted and assigned to Jazz Pharmaceuticals on February, 2019 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	10213400	February 26, 2019
‌ US Patent 10959976 Methods and compositions for treating excessive sleepiness	Patent 10959976 was granted and assigned to Jazz Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	10959976	March 30, 2021
‌ US Patent 9486426 Method of administration of gamma hydroxybutyrate with monocarboxylate transporters	Patent 9486426 was granted and assigned to Jazz Pharmaceuticals on November, 2016 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	9486426	November 8, 2016
‌ US Patent 8952029 Method of administration of gamma hydroxybutyrate with monocarboxylate transporters	Patent 8952029 was granted and assigned to Jazz Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	8952029	February 10, 2015
‌ US Patent 11410779 Sensitive drug distribution systems and methods	Patent 11410779 was granted and assigned to Jazz Pharmaceuticals on August, 2022 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	11410779	August 9, 2022
‌ US Patent 11364215 GHB formulation and method for its manufacture	Patent 11364215 was granted and assigned to Jazz Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	11364215	June 21, 2022
‌ US Patent 11160779 Methods of providing solriamfetol therapy to subjects with impaired renal function	Patent 11160779 was granted and assigned to Jazz Pharmaceuticals on November, 2021 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	11160779	November 2, 2021
‌ US Patent 9132107 Gamma-hydroxybutyrate compositions and their use for the treatment of disorders	Patent 9132107 was granted and assigned to Jazz Pharmaceuticals on September, 2015 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	9132107	September 15, 2015
‌ US Patent 11426373 Gamma-hydroxybutyrate compositions and their use for the treatment of disorders		Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	11426373	August 30, 2022
‌ US Patent 9555017 Methods of making a mixture of salts of gamma-hydroxybutyrate	Patent 9555017 was granted and assigned to Jazz Pharmaceuticals on January, 2017 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	9555017	January 31, 2017
‌ US Patent RE49361 Fused bicyclic (hetero)aromatic compounds useful for the treatment of cancers	Patent RE49361 was granted and assigned to Jazz Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	RE49361	January 10, 2023
‌ US Patent 11554102 Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders	Patent 11554102 was granted and assigned to Jazz Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	11554102	January 17, 2023
‌ US Patent 11077079 GHB formulation and method for its manufacture	Patent 11077079 was granted and assigned to Jazz Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	11077079	August 3, 2021
‌ US Patent 11147782 GHB formulation and method for its manufacture	Patent 11147782 was granted and assigned to Jazz Pharmaceuticals on October, 2021 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	11147782	October 19, 2021
‌ US Patent 10512609 Formulations of (R)-2-amino-3-phenylpropyl carbamate	Patent 10512609 was granted and assigned to Jazz Pharmaceuticals on December, 2019 by the United States Patent and Trademark Office.		Jazz Pharmaceuticals	United States Patent and Trademark Office	10512609	December 24, 2019
‌ US Patent 10675258 Method of using gamma-hydroxybutyrate compositions for the treatment of disorders	Patent 10675258 was granted and assigned to Jazz Pharmaceuticals on June, 2020 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	10675258	June 9, 2020
‌ US Patent 10864181 Method of administration of gamma hydroxybutyrate with monocarboxylate transporters	Patent 10864181 was granted and assigned to Jazz Pharmaceuticals on December, 2020 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	10864181	December 15, 2020
‌ US Patent 10710958 Carbamoyl phenylalaninol compounds and uses thereof	Patent 10710958 was granted and assigned to Jazz Pharmaceuticals on July, 2020 by the United States Patent and Trademark Office.		Jazz Pharmaceuticals	United States Patent and Trademark Office	10710958	July 14, 2020
‌ US Patent 11413264 Carbamoyl phenylalaninol analogs and uses thereof		Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	11413264	August 16, 2022
‌ US Patent 11253494 Method of administration of gamma hydroxybutyrate with monocarboxylate transporters	Patent 11253494 was granted and assigned to Jazz Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	11253494	February 22, 2022
‌ US Patent 11149000 Carbamoyl phenylalaninol compounds and uses thereof	Patent 11149000 was granted and assigned to Jazz Pharmaceuticals on October, 2021 by the United States Patent and Trademark Office.	Jazz Pharmaceuticals	Jazz Pharmaceuticals	United States Patent and Trademark Office	11149000	October 19, 2021

Results per page:

27 results

0 selected

27 results

0 selected